Can a Chronic Care Model Collaborative Reduce Heart Disease Risk in Patients with Diabetes?
- First Online:
There is a need to identify effective practical interventions to decrease cardiovascular disease risk in patients with diabetes.
We examine the impact of participation in a collaborative implementing the chronic care model (CCM) on the reduction of cardiovascular disease risk in patients with diabetes.
Controlled pre- and postintervention study.
Persons with diabetes receiving care at 13 health care organizations exposed to the CCM collaborative and controls receiving care in nonexposed sites.
Measurements and Main Results
Ten-year risk of cardiovascular disease; determined using a modified United Kingdom Prospective Diabetes Study risk engine score. A total number of 613 patients from CCM intervention sites and 557 patients from usual care control sites met the inclusion criteria. The baseline mean 10-year risk of cardiovascular disease was 31% for both the intervention group and the control group. Participants in both groups had improved blood pressure, lipid levels, and HbA1c levels during the observation period. Random intercept hierarchical regression models showed that the intervention group had a 2.1% (95% CI −3.7%, −0.5%) greater reduction in predicted risk for future cardiovascular events when compared to the control group. This would result in a reduced risk of one cardiovascular disease event for every 48 patients exposed to the intervention.
Over a 1-year interval, this collaborative intervention using the CCM lowered the cardiovascular disease risk factors of patients with diabetes who were cared for in the participating organization’s settings. Further work could enhance the impact of this promising multifactorial intervention on cardiovascular disease risk reduction.
Key wordschronic care diabetes cardiovascular disease collaborative intervention
- 7.American Diabetes Association: clinical practice recommendations 2000. Diabetes Care. 2000;23 Suppl 1:S1–116.Google Scholar
- 8.The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157(21):2413–46.Google Scholar
- 10.Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care. 1997;20(4):614–20.PubMedCrossRefGoogle Scholar
- 13.Snow V, Aronson M, Hornbake ER, Mottur-Pilson C, Weiss KB; The Clinical Efficacy Subcommittee of the American College of Physicians. Lipid control in the management of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2004;140(8):644–9.PubMedGoogle Scholar
- 16.United Kingdom Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317(7160):703–13.Google Scholar
- 26.Institute for Healthcare Improvement. The breakthrough series: IHI’s collaborative model for achieving breakthrough improvement, http://www.ihi.org/IHI/Products/WhitePapers/TheBreakthroughSeriesIHIsCollaborativeModelforAchieving%20BreakthroughImprovement, 2005. Accessed 10.12.06
- 40.National Committee for Quality Assurance. The State of Health Care Quality. 2003. 2000 L Street, NW Suite 500, Washington D.C. 20036. Page 50.Google Scholar
- 45.U.S. Department of Health and Human Services Center for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States 2003. Atlanta, GA: 2004.Google Scholar